AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Healthcare worker with hand on patient's shoulder

2 big Medicaid changes taking effect in October

| 5 Min Read
Raised hands with trophy

AMA honors 92 health systems for advancing physician well-being

| 5 Min Read
Physician uses a virtual screen or AI

How the AMA will help set the agenda for health AI’s future

| 8 Min Read
Elizabeth Lapeyre, MD, featured on "Health vs. Hype" AMA podcast

5 things to know about menopause and hormone-replacement therapy

| 6 Min Read